Table 2 Blood Count and Biochemical Profile of the participants at baseline [median (IQR)].

From: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

Parameter

Treatment Group

Favipiravir

Hydroxychloroquine

Standard Care

P-value*

N

54

51

52

 

Hemoglobin mg/dl

13.3 (12.2, 14.4)

14.0 (12.1, 15.4)

13.5 (12.3, 14.6)

0.14

White Blood Cells

4.7 (3.9, 6.3)

4.9 (4.3, 6.2)

4.7 (3.5, 6.8)

0.99

Neutrophil Count

3.0 (2.0, 4.0)

3.0 (2.0, 4.0)

3.0 (2.0, 4.0)

0.61

Neutrophil Precent

60.3 (52.1, 66.4)

59.7 (51.6, 66.7)

62.2 (51.5, 71.9)

0.69

Lymphocyte Count

1.3 (0.8, 1.6)

1.3 (0.9, 1.7)

1.1 (0.8, 1.5)

0.39

Lymphocyte Percent

29.6 (22.9, 36.7)

29.4 (24.9, 38.4)

26.7 (21.0, 37.1)

0.47

Platelets

224.5 (174.0, 303.0)

188.0 (146.0, 226.0)

192.0 (149.0, 234.0)

0.012

Sodium mmol/l

138.0 (137.0, 140.0)

138.0 (136.0, 141.0)

139.0 (136.0, 140.5)

0.73

Potassium mmol/l

4.3 (4.0, 4.6)

4.3 (3.9, 4.6)

4.5 (4.1, 4.8)

0.090

Urea mmol/l

4.2 (3.3, 5.0)

3.9 (3.0, 4.5)

4.7 (3.6, 6.0)

0.002

Creatinine umol/l

61.5 (51.0, 73.0)

60.0 (50.0, 71.0)

61.5 (54.0, 71.5)

0.76

Lactate dehydrogenase mmol/l

217.0 (174.0, 271.0)

211.0 (178.0, 262.0)

214.0 (182.0, 311.5)

0.76

C-Reactive Protein mmol/l

16.8 (4.0, 32.1)

14.9 (4.2, 32.5)

17.4 (5.3, 58.4)

0.42

Uric Acid mmol/l

277.0 (203.0, 327.0)

253.0 (206.0, 331.5)

310.0 (243.0, 395.0)

0.062

Vitamin D nmol/l

30.5 (22.0, 44.0)

32.0 (23.0, 40.0)

32.5 (22.0, 47.0)

0.73

Ferritin mmol/l

152.1 (49.1, 354.6)

222.6 (78.5, 392.2)

198.2 (118.3, 337.3)

0.52

DDimer mmol/l

0.4 (0.3, 0.7)

0.4 (0.2, 0.6)

0.5 (0.3, 1.0)

0.27

Lactate, mmol/l

1.4 (1.1, 1.8)

1.6 (1.1, 2.1)

1.7 (1.2, 2.0)

0.27

  1. *P-values are based on Kruskal–Wallis test.